Can Anorexia Increase the Risk of Miscarriage?

Anorexia Nervosa (AN) is a serious eating disorder characterized by an intense fear of gaining weight, a distorted body image, and severely restricted caloric intake. When a person with active AN or a history of the condition becomes pregnant, the pregnancy is immediately categorized as high-risk. Miscarriage, defined as the spontaneous loss of a pregnancy before the 20th week, is one of the many severe adverse outcomes linked to this underlying health condition. The profound nutritional and hormonal disruption caused by AN significantly compromises the environment necessary for a developing fetus. The interaction between maternal malnutrition and the physiological demands of pregnancy creates a dangerous scenario that substantially increases the likelihood of pregnancy loss and other complications.

Statistical Connection Between Anorexia and Miscarriage Risk

While defining a precise relative risk for miscarriage in individuals with AN is challenging due to variations in study design and illness severity, epidemiological data consistently point to a heightened danger. Studies examining women with a history of AN have shown a higher incidence of miscarriage compared to the general population. The risk appears to be more pronounced when the eating disorder is active during pregnancy or the individual has a history of severe illness requiring hospitalization. The overall rate of early pregnancy loss among women with an eating disorder history is a major concern for obstetric providers. The condition places the pregnancy into a significantly higher-risk category than the average baseline risk for the population, underscoring the necessity for proactive and specialized medical monitoring.

Physiological Factors Contributing to Pregnancy Loss

The primary drivers of early pregnancy loss in AN are the severe hormonal imbalances and nutritional deficits inherent to the disorder. Caloric restriction and low body fat suppress the hypothalamic-pituitary-ovarian (HPO) axis, which is the control center for reproductive hormones. This suppression leads to a reduction in the pulsatile release of Gonadotropin-Releasing Hormone (GnRH), subsequently lowering the production of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).

The result is a deficiency in progesterone and estrogen, the two hormones necessary for sustaining a pregnancy, especially in the first trimester. Progesterone is responsible for maintaining the uterine lining and promoting successful implantation of the embryo. Low levels of this hormone can destabilize the uterine environment, leading to a failure of implantation or the spontaneous rejection of the pregnancy. Furthermore, the chronically low body mass index (BMI) associated with AN is itself an independent risk factor for implantation failure and poor placental development.

Chronic malnutrition depletes the maternal stores of essential micronutrients and macronutrients needed for fetal growth and placental function. The lack of sufficient protein, essential fatty acids, and vitamins, such as Vitamin D and B vitamins, can impair the early developmental processes of the placenta and embryo. This deficiency compromises the structural integrity and function of the placenta, which is the lifeline for the fetus. The body’s starvation response prioritizes the mother’s survival, which can result in the fetus not receiving the nutritional support required to survive the early, vulnerable stages of development.

Related Maternal and Fetal Health Outcomes

Beyond the risk of miscarriage, AN is associated with a spectrum of adverse outcomes for both the pregnant individual and the fetus. For the fetus, risks include a 1.5 to 1.7 times higher risk of being born small for gestational age (SGA) or experiencing intrauterine growth restriction (IUGR). Fetal growth restriction occurs because the limited nutrient supply forces the fetus to adapt by prioritizing blood flow to the brain at the expense of other organs, which can lead to long-term health issues.

Preterm delivery is also a significantly elevated risk, with studies showing women with AN have an approximately 1.3 to 1.6 times increased likelihood of giving birth before 37 weeks gestation. The risk of stillbirth is nearly doubled compared to the general population, reported at 1.99 times greater in some cohorts. Maternal complications are common, including a doubled risk of developing hyperemesis gravidarum (severe nausea and vomiting) and anemia during pregnancy. Women with AN face higher rates of obstetric complications like antepartum hemorrhage and a greater need for cesarean section delivery.

Specialized Prenatal Care and Support Strategies

Managing a pregnancy when a person has AN requires a highly coordinated, multidisciplinary approach to mitigate the inherent risks. The care team must include an obstetrician specializing in high-risk pregnancies, a registered dietitian with expertise in both eating disorders and prenatal nutrition, and a mental health professional. This collaborative team is necessary to address the complex medical, nutritional, and psychological needs concurrently.

Nutritional intervention focuses on establishing healthy weight gain targets and closely monitoring for micronutrient deficiencies, particularly electrolytes, iron, and specific vitamins. The dietitian works to create a specialized meal plan that supports both the individual’s recovery goals and the nutritional demands of the developing fetus. Regular monitoring of fetal growth via ultrasound is performed more frequently than in a standard pregnancy to detect signs of growth restriction or distress early.

Psychological support, often involving cognitive-behavioral therapy (CBT) or other specialized therapies, is provided to help the expectant mother manage body image concerns and the fear of weight gain that pregnancy entails. Addressing the underlying mental health issues is paramount, as the stress of pregnancy can trigger a relapse in eating disorder behaviors. Proactive planning for the postpartum period is also implemented to address the high risk of symptom recurrence after delivery.